26 assets in Uterine Cervix Neoplasm

Therapeutic assets addressing Uterine Cervix Neoplasm, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Cis-Diamminedichloroplatinum Ii Uterine Cervix Neoplasm	Merck Sharp & Dohme LLC	P3	BB (65)
Pembrolizumab Uterine Cervix Neoplasm	GV20 Therapeutics	P3	BB (64)
Carboplatin Uterine Cervix Neoplasm	Eli Lilly and Company	P2	B (61)
Fulvestrant Uterine Cervix Neoplasm	Atavistik Bio, Inc	P2	B (60)
Capecitabine Uterine Cervix Neoplasm	Merck Sharp & Dohme LLC	P2	B (57)
Docetaxel Uterine Cervix Neoplasm	Merck Sharp & Dohme LLC	P2	B (57)
Fluorouracilum Uterine Cervix Neoplasm	Merck Sharp & Dohme LLC	P2	B (57)
Lenvatinib Uterine Cervix Neoplasm	Merck Sharp & Dohme LLC	P2	B (57)
Pembrolizumab/Vibostolimab Coformulation Uterine Cervix Neoplasm	Merck Sharp & Dohme LLC	P2	B (57)
Adriamycin Uterine Cervix Neoplasm	Yonsei University	P2	CCC (53)
Dostarlimab Uterine Cervix Neoplasm	Yonsei University	P2	CCC (53)
Immunoglobulin G1, Anti-(Human Epidermal Growth Factor Receptor Her2) (Human-Mus Musculus Monoclonal Shr-1805 ?1-Chain), Complex With Human-Mus Musculus Monoclonal Shr-1805 ?-Chain, Dimer, Thioether With N-[6-(3-Mercapto-2,5-Dioxo-1-Pyrrolidinyl)-1-Oxohexyl]Glycylglycyl-L-Phenylalanyl-N-[[(1R)-1-Cyclopropyl-2-[[(1S,9S)-9-Ethyl-5-Fluoro-2,3,9,10,13,15-Hexahydro-9-Hydroxy-4-Methyl-10,13-Dioxo-1H,12H-Benzo[De]Pyrano[3?,4?:6,7]Indolizino[1,2-B]Quinolin-1-Yl]Amino]-2-Oxoethoxy]Methyl]Glycinamide Uterine Cervix Neoplasm	Haihua Yuan	P2	CCC (53)
Trastuzumab Uterine Cervix Neoplasm	Seagen, a wholly owned subsidiary of Pfizer	P2	CCC (53)
Tucatinib Uterine Cervix Neoplasm	Seagen, a wholly owned subsidiary of Pfizer	P2	CCC (53)
Zanidatamab Uterine Cervix Neoplasm	Haihua Yuan	P2	CCC (53)
Oxaliplatin Uterine Cervix Neoplasm	Merck Sharp & Dohme LLC	P2	CCC (52)
Atezolizumab Uterine Cervix Neoplasm	Cancer Research UK	P1/2	CC (45)
htl0039732 capsules Uterine Cervix Neoplasm	Cancer Research UK	P1/2	CC (45)
ucb4594 Uterine Cervix Neoplasm	Cancer Research UK	P1/2	CC (45)
Ganciclovir Uterine Cervix Neoplasm	Gene Surgery LLC	P1	CC (44)
Stimotimagene Copolymerplasmid Uterine Cervix Neoplasm	Gene Surgery LLC	P1	CC (44)
Atv-1601 Uterine Cervix Neoplasm	Atavistik Bio, Inc	P1	CC (43)
Itraconazole Uterine Cervix Neoplasm	Eli Lilly and Company	P1	CC (41)
ly4170156 Uterine Cervix Neoplasm	Eli Lilly and Company	P1	CC (41)
Sgn-Alpv Uterine Cervix Neoplasm	Seagen Inc.	P1	CC (41)
Sigvotatug Vedotin Uterine Cervix Neoplasm	Seagen, a wholly owned subsidiary of Pfizer	P1	CC (41)